GTS Securities’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-40,029
Closed -$497K 4016
2024
Q1
$497K Buy
40,029
+24,514
+158% +$320K ﹤0.01% 2584
2023
Q4
$217K Sell
15,515
-6,172
-28% -$85.7K ﹤0.01% 3498
2023
Q3
$320K Buy
21,687
+8,053
+59% +$113K ﹤0.01% 3006
2023
Q2
$176K Buy
+13,634
New +$155K 0.01% 1061

Other funds holding DVAX

GTS Securities's DVAX Position: Q2 2024 in Review

GTS Securities sold out of Dynavax Technologies (DVAX) in Q2 2024, closing a stake of 40,029 shares — an estimated $497K sold.

GTS Securities first reported a position in DVAX in Q2 2023 and held it in 4 quarters. The position peaked at $497K in Q1 2024. 238 funds tracked by Wall St. Rank hold DVAX as of Q2 2024.

  • GTS Securities reported no remaining Dynavax Technologies position as of Q2 2024 after selling out during the quarter.
  • GTS Securities sold 40,029 Dynavax Technologies shares in Q2 2024, an estimated $497K.
  • GTS Securities first reported a position in Dynavax Technologies in Q2 2023 and held it in 4 quarters.
  • GTS Securities's Dynavax Technologies position peaked at $497K in Q1 2024.
  • 238 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2024.

Based on GTS Securities's 13F filing for Q2 2024, filed 14 Aug 2024.